Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Virus entry into a susceptible host cell is the first step in the formation of all viral diseases. Controlling viral infections by disrupting viral entry is advantageous for antibody-mediated neutralization by the host’s immune system and as a preventive and therapeutic antiviral strategy. Recently, several plant-derived carbohydrate-binding proteins (lectins) have emerged as a new class of antiviral biologics by taking advantage of a unique glycosylation pattern only found on the surface of viruses. In particular, a red algae-derived griffithsin (GRFT) protein has demonstrated superior in vitro and in vivo antiviral activity with minimum host toxicity against a variety of clinically relevant, enveloped viruses. This review examines the structural characteristics of GRFT, focusing on its carbohydrate-binding capability. Its in vitro antiviral profiles against human immunodeficiency virus (HIV) are also discussed followed by a description of the results from a combination study using anti-HIV drugs. The results of several studies regarding its novel antiviral mechanism of action are provided in conjunction with an explanation of viral resistance profiles to GRFT. In addition, its in vitro and in vivo host toxicity profiles are summarized with its pharmacokinetic behavior using in vivo efficacy study results. Also, a large-scale production and formulation strategy, as well as a drug delivery strategy, for GRFT as a new class of broad-spectrum microbicides is discussed. Finally, results from two ongoing clinical studies examining GRFT’s effects on viruses are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The amino acid sequence of griffithsin (GRFT). Corresponding secondary β-sheet structures are marked with yellow arrows based on the crystal structure of a GRFT dimer with mannose at a resolution of 1.78 Å [19]. Tyrosine and aspartate residues in three carbohydrate-binding domains, which are essential for mannose-binding, are noted with blue and orange arrows, respectively. Wild-type GRFT has a non-standard amino acid at position 31, but it is replaced by alanine (colored in red) in recombinant GRFT. The sequence display was generated by the RCSB protein data bank website (www.rcsb.org).](https://figures.cochat.ai/paper-figures/1fd42505c6ef428985401d5005e46d4b/griffithsin-a-highly-potent-broad-spectrum-antiviral-lectin-from-red-algae-from-figure-1.jpg)
![Figure 2 The crystal structure of a GRFT dimer with six mannoses at a resolution of 1.78 Å [19]. Each GRFT monomer is presented in either red or blue. Six bound mannose molecules are shown with ball and stick models. This image was created with PDB ID and associated publication, NGL Viewer (AS Rose et al. (2018) NGL viewer: web-based molecular graphics for large complexes. Bioinformatics doi:10.1093/bioinformatics/bty419), and RCSB PDB.](https://figures.cochat.ai/paper-figures/bc6833ca02e5443ca2b5789603c52e60/griffithsin-a-highly-potent-broad-spectrum-antiviral-lectin-from-red-algae-from-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some cyanobacteria and microalgae contain specific compounds which have been shown to have potent antiviral properties.”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Lee, 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This includes red algae lectins such as griffithsin from marine Griffithsia sp. (Lee, 2019) and cyanobacterial lectins such as Cyanovirin-N from freshwater Nostoc ellipsosporum (Lotfi et al., 2018).”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Lee, 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Global epidemiology of HIV infection in men who have sex with men
Beyrer, C., Baral, S. D., van Griensven, F., Goodreau, S. M., Chariyalertsak, S., Wirtz, A. L., & Brookmeyer, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60821-6 · Cited by 1,559
Mori, T., O'Keefe, B. R., Sowder, R. C., Bringans, S., Gardella, R., Berg, S., Cochran, P., Turpin, J. A., Buckheit, R. W., McMahon, J. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411122200 · Cited by 445
O'Keefe, B. R., Giomarelli, B., Barnard, D. L., Shenoy, S. R., Chan, P. K. S., McMahon, J. B., Palmer, K. E., Barnett, B. W., Meyerholz, D. K., Wohlford-Lenane, C. L., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02322-09 · Cited by 303
O'Keefe, B. R., Vojdani, F., Buffa, V., Shattock, R. J., Montefiori, D. C., Bakke, J., Mirsalis, J., d'Andrea, A.-L., Hume, S. D., Bratcher, B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901506106 · Cited by 262
A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication
Swanson, M. D., Winter, H. C., Goldstein, I. J., & Markovitz, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034926 · Cited by 214
Toxicity of antiretroviral therapy and implications for drug development
Carr, A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1151 · Cited by 191
Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin
O'Keefe, B. R., Smee, D. F., Turpin, J. A., Saucedo, C. J., Gustafson, K. R., Mori, T., Blakeslee, D., Buckheit, R., & Boyd, M. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2518-2525.2003 · Cited by 188
Ziółkowska, N. E., O'Keefe, B. R., Mori, T., Zhu, C., Giomarelli, B., Vojdani, F., Palmer, K. E., McMahon, J. B., & Wlodawer, A. (2006) · Structure · doi:10.1016/j.str.2006.05.017 · Cited by 172
Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential
Lusvarghi, S., & Bewley, C. A. (2016) · Viruses · doi:10.3390/v8100296 · Cited by 164
Griffithsin Has Antiviral Activity against Hepatitis C Virus
Meuleman, P., Albecka, A., Belouzard, S., Vercauteren, K., Verhoye, L., Wychowski, C., Leroux-Roels, G., Palmer, K. E., & Dubuisson, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-11 · Cited by 160
Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin
Millet, J. K., Séron, K., Labitt, R. N., Danneels, A., Palmer, K. E., Whittaker, G. R., Dubuisson, J., & Belouzard, S. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.07.011 · Cited by 150
Takebe, Y., Saucedo, C. J., Lund, G., Uenishi, R., Hase, S., Tsuchiura, T., Kneteman, N., Ramessar, K., Tyrrell, D. L. J., Shirakura, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064449 · Cited by 141
Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti‐HIV microbicide
Emau, P., Tian, B., O’Keefe, B., Mori, T., McMahon, J. B., Palmer, K. E., Jiang, Y., Bekele, G., & Tsai, C. (2007) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2007.00242.x · Cited by 135
Huskens, D., Férir, G., Vermeire, K., Kehr, J.-C., Balzarini, J., Dittmann, E., & Schols, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128546 · Cited by 127
Barton, C. R., Kouokam, J. C., Lasnik, A. B., Foreman, O., Cambon, A. C., Brock, G. N., Montefiori, D. C., Vojdani, F., McCormick, A. A., O’Keefe, B. R., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01407-13 · Cited by 123
Kouokam, J. C., Huskens, D., Schols, D., Johannemann, A. S., Riedell, S. K., Walter, W., Walker, J. M., Matoba, N., O’Keefe, B. R., & Palmer, K. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022635 · Cited by 117
Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread
Nixon, B. G., Stefanidou, M., Mesquita, P. M. M., Fakioglu, E., Segarra, T. J., Rohan, L. C., Halford, W. P., Palmer, K. E., & Herold, B. C. (2013) · Journal of Virology · doi:10.1128/jvi.00012-13 · Cited by 113
Alexandre, K. B., Gray, E. S., Lambson, B. E., Moore, P. L., Choge, I., Mlisana, K. P., Karim, S. S. A., McMahon, J. B., O’Keefe, B. R., Chikwamba, R., et al. (2010) · Virology · doi:10.1016/j.virol.2010.03.021 · Cited by 112
Yang, H., Li, J., Patel, S. K., Palmer, K. E., Devlin, B., & Rohan, L. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11040184 · Cited by 104
Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus
Levendosky, K., Mizenina, O., Martinelli, E., Jean-Pierre, N., Kizima, L., Rodriguez, A., Kleinbeck, K., Bonnaire, T., Robbiani, M., Zydowsky, T. M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01816-15 · Cited by 99
Moulaei, T., Shenoy, S. R., Giomarelli, B., Thomas, C., McMahon, J. B., Dauter, Z., O’Keefe, B. R., & Wlodawer, A. (2010) · Structure · doi:10.1016/j.str.2010.05.016 · Cited by 97
Degradation of naturally occurring and engineered antimicrobial peptides by proteases
Moncla, B. J., Pryke, K. M., Rohan, L. C., & Graebing, P. W. (2011) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2011.26059 · Cited by 95
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo
Derby, N. R., Lal, M., Aravantinou, M., Kizima, L., Barnable, P., Rodríguez, A., Lai, M., Wesenberg, A., Ugaonkar, S. R., Levendosky, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06349-0 · Cited by 90
Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo
Ishag, H. Z. A., Li, C., Huang, L., Sun, M., Wang, F., Ni, B., Malik, T., Chen, P., & Mao, X. (2012) · Archives of Virology · doi:10.1007/s00705-012-1489-2 · Cited by 85
Grifonin-1: A Small HIV-1 Entry Inhibitor Derived from the Algal Lectin, Griffithsin
Micewicz, E. D., Cole, A. L., Jung, C.-L., Luong, H., Phillips, M. L., Pratikhya, P., Sharma, S., Waring, A. J., Cole, A. M., & Ruchala, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014360 · Cited by 80
Ziolkowska, N. E., Shenoy, S. R., O’Keefe, B. R., McMahon, J. B., Palmer, K. E., Dwek, R. A., Wormald, M. R., & Wlodawer, A. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21336 · Cited by 67
Binding of the Mannose-Specific Lectin, Griffithsin, to HIV-1 gp120 Exposes the CD4-Binding Site
Alexandre, K. B., Gray, E. S., Pantophlet, R. A., Moore, P. L., McMahon, J. B., Chakauya, E., O’Keefe, B. R., Chikwamba, R., & Morris, L. (2011) · Journal of Virology · doi:10.1128/jvi.02675-10 · Cited by 65
Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture
Giomarelli, B., Schumacher, K. M., Taylor, T. E., Sowder, R. C., Hartley, J. L., McMahon, J. B., & Mori, T. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.10.014 · Cited by 63
Férir, G., Palmer, K. E., & Schols, D. (2011) · Virology · doi:10.1016/j.virol.2011.07.004 · Cited by 60
Hahn, S., Giritch, A., Bartels, D., Bortesi, L., & Gleba, Y. Y. (2014) · Plant Biotechnology Journal · doi:10.1111/pbi.12299 · Cited by 59
Xue, J., Hoorelbeke, B., Kagiampakis, I., Demeler, B., Balzarini, J. M., & LiWang, P. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00332-13 · Cited by 53
Alexandre, K. B., Gray, E. S., Mufhandu, H., McMahon, J. B., Chakauya, E., O'Keefe, B. R., Chikwamba, R., & Morris, L. (2012) · Virology · doi:10.1016/j.virol.2011.12.001 · Cited by 52
Vamvaka, E., Arcalís, E., Ramessar, K., Evans, A. B., O’Keefe, B. R., Shattock, R. J., Medina, V., Stöger, E., Christou, P., & Capell, T. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12507 · Cited by 47
Xue, J., Gao, Y., Hoorelbeke, B., Kagiampakis, I., Zhao, B., Demeler, B., Balzarini, J., & LiWang, P. J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300194b · Cited by 46
Barton, C. R., Kouokam, J. C., Hurst, H. E., & Palmer, K. E. (2016) · Viruses · doi:10.3390/v8120331 · Cited by 44
Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus
Moulaei, T., Alexandre, K. B., Shenoy, S. R., Meyerson, J. R., Krumpe, L. R. H., Constantine, B., Wilson, J. A., Buckheit, R. W., McMahon, J. B., Subramaniam, S., et al. (2015) · Retrovirology · doi:10.1186/s12977-014-0127-3 · Cited by 43
Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection
Grooms-Williams, T. W., Vuong, H. R., Tyo, K. M., Malik, D. A., Sims, L. B., Whittington, C. P., Palmer, K. E., Matoba, N., & Steinbach-Rankins, J. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00956-16 · Cited by 43
Férir, G., Huskens, D., Palmer, K. E., Boudreaux, D. M., Swanson, M. D., Markovitz, D. M., Balzarini, J. M., & Schols, D. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0026 · Cited by 42
Kouokam, J. C., Lasnik, A. B., & Palmer, K. E. (2016) · Viruses · doi:10.3390/v8110311 · Cited by 41
Improving the large scale purification of the HIV microbicide, griffithsin
Fuqua, J. L., Wanga, V., & Palmer, K. E. (2015) · BMC Biotechnology · doi:10.1186/s12896-015-0120-5 · Cited by 40
Ziolkowska, N. E., Shenoy, S. R., O’Keefe, B. R., & Wlodawer, A. (2007) · Protein Science · doi:10.1110/ps.072889407 · Cited by 40
Lal, M., Lai, M., Ugaonkar, S. R., Wesenberg, A., Kizima, L., Rodríguez, A., Levendosky, K., Mizenina, O. A., Fernández-Romero, J. A., & Zydowsky, T. M. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.06.002 · Cited by 38
In vitro antiviral activity of Griffithsin against porcine epidemic diarrhea virus
Li, L., Yu, X., Zhang, H., Cheng, H., Hou, L., Zheng, Q., & Hou, J. (2019) · Virus Genes · doi:10.1007/s11262-019-01633-7 · Cited by 37
Huang, X., Jin, W., Griffin, G. E., Shattock, R. J., & Hu, Q. (2011) · Journal of General Virology · doi:10.1099/vir.0.033092-0 · Cited by 36
Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41
Kagiampakis, I., Gharibi, A., Mankowski, M. K., Snyder, B. A., Ptak, R. G., Alatas, K., & LiWang, P. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00376-10 · Cited by 33
Girard, L., Birse, K., Holm, J. B., Gajer, P., Humphrys, M. S., Garber, D. A., Guenthner, P. C., Noël‐Romas, L., Abou, M., McCorrister, S. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26313-8 · Cited by 33
Banerjee, K., Michael, E., Eggink, D., van Montfort, T., Lasnik, A. B., Palmer, K. E., Sanders, R. W., Moore, J. P., & Klasse, P. J. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0101 · Cited by 32
Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm
Vamvaka, E., Farré, G., Molinos-Albert, L. M., Evans, A. B., Canela-Xandri, A., Twyman, R. M., Carrillo, J., Ordóñez, R. A., Shattock, R. J., O’Keefe, B. R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806022115 · Cited by 32
pH-responsive delivery of Griffithsin from electrospun fibers
Tyo, K. M., Duan, J., Kollipara, P., Cerna, M. V. C. D., Lee, D., Palmer, K. E., & Steinbach-Rankins, J. M. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.04.013 · Cited by 31
Ishag, H. Z. A., Li, C., Wang, F., & Mao, X. (2016) · Virus Research · doi:10.1016/j.virusres.2016.01.016 · Cited by 29
Hoelscher, M., Tiller, N., Teh, A. Y., Wu, G., K‐C., J., & Bock, R. (2018) · Plant Molecular Biology · doi:10.1007/s11103-018-0744-7 · Cited by 29
Engineering Lactobacillus rhamnosus GG and GR-1 to express HIV-inhibiting griffithsin
Petrova, M., van den Broek, M. F. L., Spacova, I., Verhoeven, T. L. A., Balzarini, J. M., Vanderleyden, J., Schols, D., & Lebeer, S. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.07.013 · Cited by 29
Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN
Alexandre, K. B., Moore, P. L., Nonyane, M., Gray, E. S., Ranchobe, N., Chakauya, E., McMahon, J. B., O’Keefe, B. R., Chikwamba, R., & Morris, L. (2013) · Virology · doi:10.1016/j.virol.2013.07.019 · Cited by 28
Lusvarghi, S., Lohith, K., Morin‐Leisk, J., Ghirlando, R., Hinshaw, J. E., & Bewley, C. A. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00139 · Cited by 26
Hoorelbeke, B., Xue, J., LiWang, P. J., & Balzarini, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064132 · Cited by 24
Zuend, C. F., Nomellini, J. F., Smit, J., & Horwitz, M. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21134-1 · Cited by 18
Janahi, E. M. A., Haque, S., Akhter, N., Wahid, M., Jawed, A., Mandal, R. K., Lohani, M., Areeshi, M. Y., Almalki, S. S. R., Das, S., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.06.002 · Cited by 16
Kim, B. M., Lotter-Stark, T., Rybicki, E. P., Chikwamba, R., & Palmer, K. E. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12917 · Cited by 13
Hu, B., Du, T., Li, C., Luo, S., Liu, Y., Huang, X., & Hu, Q. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000299 · Cited by 12
Hepatitis C Virus Resistance to Carbohydrate-Binding Agents
Izquierdo, L., Oliveira, C., Fournier, C., Descamps, V., Morel, V., Dubuisson, J., Brochot, É., François, C., Castelain, S., Duverlie, G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149064 · Cited by 12
Férir, G. (2012) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.1000054 · Cited by 11
Zuend, C. F., Nomellini, J. F., Smit, J., & Horwitz, M. S. (2019) · Journal of Virology · doi:10.1128/jvi.00614-19 · Cited by 8
Cited by
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.044 · Cited by 1,016
Michalak, I., Tiwari, R., Dhawan, M. K., Alagawany, M. M., Farag, M. R., Sharun, K., Emran, T. B., & Dhama, K. (2022) · Veterinary Quarterly · doi:10.1080/01652176.2022.2061744 · Cited by 173
Pereira, L., & Critchley, A. T. (2020) · Journal of Applied Phycology · doi:10.1007/s10811-020-02143-y · Cited by 115
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Almehdi, A. M., Khoder, G., Alchakee, A., Alsayyid, A. T., Sarg, N. H., & Soliman, S. S. M. (2021) · Infection · doi:10.1007/s15010-021-01677-8 · Cited by 123
Unlocking the potential of marine biodiscovery
Sigwart, J. D., Blasiak, R., Jaspars, M., Jouffray, J., & Taşdemir, D. (2020) · Natural Product Reports · doi:10.1039/d0np00067a · Cited by 114
Metadata
- Authors
- Lee, C.
- Affiliations
- College of Pharmacy, Dongguk University, Goyang 10326, Korea
- ORCID
- Lee, Choongho
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-10-06
- Volume
- 17
- Issue
- 10
- Pages
- 567
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC6835697
- OpenAlex
- W2979023383
- Cited by
- 138
- References
- 64
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 20 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 19
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (NRF) (NRF-2019R1F1A1058628)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- griffithsin, antiviral lectin, red algae, carbohydrate-binding proteins, viral entry inhibition, HIV, microbicides, host toxicity, pharmacokinetics, drug resistance, combination antiviral therapy, drug delivery, clinical trials
- MeSH terms
- Rhodophyta, Amino Acid Sequence, Animals, Antiviral Agents, Humans, HIV-1, HIV Infections, Plant Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.